Genisphere

About:

Genisphere is a nanotechnology company.

Website: http://genisphere.com/

Twitter/X: genisphere

Description:

Genisphere is a nanotechnology company providing innovative tools for targeted drug delivery, clinical diagnostics and life science research based on the company’s 3DNA nanoparticle platform. Genisphere's unique, IP-protected, 3DNA technology has broad applicability to improve the sensitivity in immunoassay and nucleic acid detection platforms, as well as to deliver therapeutics in a highly specific manner. Genisphere has successfully out-licensed several reagent kits to the research market, and provides customized products to improve the limit of detection of high-sensitivity lateral flow point-of-care tests, enabling their commercialization. Genisphere's diagnostic partners have a competitive advantage due to 3DNA’s ability to improve their test’s sensitivity, with minimal additional costs and no alterations to end user protocols. For targeted therapeutics, Genisphere provides a fully customizable all-DNA drug delivery platform. Genisphere's robust nanocarrier delivers small drug, RNAi and gene construct therapeutics with greatly improved efficacy and reduced toxicity. The company is continuing to seek partnerships with biotechnology and pharmaceutical companies that could benefit from Genisphere's platform technology.

Total Funding Amount:

$6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Hatfield, Pennsylvania, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)genisphere.com

Founders:

James Kadushin

Number of Employees:

11-50

Last Funding Date:

2015-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai